ARK Investment Management’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,045
| Closed | -$1.17M | – | 301 |
|
|
2022
Q2 | $1.17M | Buy |
1,045
+183
| +21% | +$205K | 0.01% | 230 |
|
|
2022
Q1 | $2.17M | Buy |
+862
| New | +$2.17M | 0.01% | 218 |
|
|
2021
Q4 | – | Sell |
-19
| Closed | -$88K | – | 360 |
|
|
2021
Q3 | $88K | Sell |
19
-768
| -98% | -$3.56M | ﹤0.01% | 282 |
|
|
2021
Q2 | $5.42M | Buy |
787
+11
| +1% | +$75.7K | 0.01% | 220 |
|
|
2021
Q1 | $5.68M | Buy |
776
+609
| +365% | +$4.46M | 0.01% | 209 |
|
|
2020
Q4 | $1.35M | Buy |
167
+44
| +36% | +$355K | ﹤0.01% | 202 |
|
|
2020
Q3 | $1.26M | Sell |
123
-23
| -16% | -$235K | 0.01% | 144 |
|
|
2020
Q2 | $979K | Buy |
146
+50
| +52% | +$335K | 0.01% | 162 |
|
|
2020
Q1 | $436K | Buy |
96
+38
| +66% | +$173K | 0.01% | 138 |
|
|
2019
Q4 | $354K | Buy |
58
+2
| +4% | +$12.2K | 0.01% | 172 |
|
|
2019
Q3 | $393K | Sell |
56
-4
| -7% | -$28.1K | 0.01% | 167 |
|
|
2019
Q2 | $389K | Sell |
60
-6
| -9% | -$38.9K | 0.01% | 160 |
|
|
2019
Q1 | $548K | Buy |
66
+5
| +8% | +$41.5K | 0.02% | 119 |
|
|
2018
Q4 | $337K | Buy |
61
+12
| +24% | +$66.3K | 0.01% | 140 |
|
|
2018
Q3 | $434K | Sell |
49
-64
| -57% | -$567K | 0.01% | 153 |
|
|
2018
Q2 | $961K | Buy |
113
+9
| +9% | +$76.5K | 0.04% | 104 |
|
|
2018
Q1 | $534K | Buy |
104
+75
| +259% | +$385K | 0.03% | 130 |
|
|
2017
Q4 | $149K | Buy |
+29
| New | +$149K | 0.01% | 159 |
|